Stock listing

HKEX:2617 TransThera Sciences (Nanjing). Inc. (藥捷安康) 股價

Home listing (HKEX) of TransThera Sciences (Nanjing). Inc.

Follow TransThera Sciences (Nanjing). Inc. into a list and get an email when it puts out news.

Share price · HKEX:2617

$6.45 HKD -0.50 (-7.2%)

Close on Nov 20, 2026

Past year -97.0% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$6.35 – $6.70 HKDNov 20, 2026
Volume
2.52M sharesNov 20, 2026
Market cap
$2.02B HKDAt the close on Nov 20, 2026 · price × 312.5M shares outstanding
52-week range
$6.35 – $217.20 HKDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$42.54M HKDMedian day 3.13M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
TransThera Sciences (Nanjing). Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
HKEX:2617 · Home$6.45 HKD-0.50 (-7.2%)2,520,000$6.39$6.70$6.345$6.95Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · HKEX:2617 · HKD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$6.45-0.50-7.2%$6.39$6.70$6.3452,520,000
$6.95-0.18-2.5%$7.165$7.275$6.922,135,010
$7.13-0.13-1.8%$7.285$7.315$7.071,667,500
$7.26-0.315-4.2%$7.80$7.80$7.222,101,000
$7.575-0.40-5.0%$7.985$8.065$7.572,633,000
$7.975-0.18-2.2%$8.39$8.39$7.9252,487,500
$8.155-0.125-1.5%$8.26$8.265$8.062,142,500
$8.28+0.24+3.0%$8.19$8.30$8.131,958,780
$8.04-0.045-0.6%$8.18$8.38$8.042,368,397
$8.085-0.26-3.1%$8.11$8.235$8.0452,450,500
$8.345+0.415+5.2%$7.995$8.42$7.9955,987,000
$7.93+0.12+1.5%$7.99$8.055$7.713,782,500
$7.81-0.09-1.1%$7.905$8.48$7.755,637,000
$7.90-0.50-6.0%$8.565$8.565$7.534,968,000
$8.40-0.255-2.9%$8.87$9.395$8.4013,363,000
$8.655-0.055-0.6%$8.80$9.18$8.624,707,500
$8.71+0.23+2.7%$8.545$8.84$8.511,850,000
$8.48-0.385-4.3%$8.98$8.98$8.422,845,500
$8.865+0.06+0.7%$8.80$8.98$8.5651,462,000
$8.805+0.265+3.1%$8.55$9.00$8.353,363,000
$8.54-0.53-5.8%$9.075$9.09$8.4553,579,000
$9.07-0.025-0.3%$9.245$9.315$9.051,517,500
$9.095-0.18-1.9%$9.39$9.39$9.091,720,500
$9.275+0.14+1.5%$9.33$9.70$9.204,337,500
$9.135-0.20-2.1%$9.39$9.455$9.062,454,000
$9.335-0.275-2.9%$9.685$9.69$9.3351,924,000
$9.61-0.39-3.9%$9.85$10.00$9.442,790,500
$10.00-0.43-4.1%$10.48$10.64$9.9153,151,500
$10.43+0.36+3.6%$10.19$10.65$9.814,705,500
$10.070.000.0%$10.47$10.68$9.974,320,500
$10.07-0.06-0.6%$10.07$10.14$9.525421,002
$10.13-0.09-0.9%$10.28$10.46$10.13365,500
$10.22-0.50-4.7%$10.48$10.52$10.10296,500
$10.72-0.22-2.0%$10.59$10.72$10.09647,500
$10.94+0.82+8.1%$10.12$11.06$10.088,780,500
$10.12+0.06+0.6%$10.10$10.24$9.981,916,500
$10.06+0.03+0.3%$10.23$10.56$9.903,110,500
$10.03-0.30-2.9%$10.48$10.48$9.86496,500
$10.33-0.28-2.6%$10.54$10.69$10.222,951,500
$10.61-0.14-1.3%$10.85$11.49$10.5512,522,500
$10.75-0.37-3.3%$11.03$11.25$10.619,906,500
$11.12+1.09+10.9%$10.38$11.73$10.2435,768,000
$10.03+0.62+6.6%$9.50$10.25$9.5010,386,810
$9.41+0.05+0.5%$9.58$9.59$9.2952,514,500
$9.36-0.18-1.9%$9.62$9.64$9.312,073,000
$9.54-0.03-0.3%$9.615$9.88$9.543,396,000
$9.57+0.195+2.1%$9.55$10.19$9.247,250,000
$9.375-0.085-0.9%$9.425$9.49$9.013,498,500
$9.46+0.06+0.6%$9.445$9.49$9.2552,176,000
$9.40-0.285-2.9%$9.80$9.80$9.383,406,500
$9.685-0.155-1.6%$9.925$9.925$9.663,164,000
$9.84-0.31-3.1%$10.15$10.22$9.795,293,000
$10.15+0.06+0.6%$10.14$10.49$10.024,975,000
$10.09+0.06+0.6%$10.16$10.24$9.9752,486,000
$10.03-0.05-0.5%$10.20$10.22$9.9653,586,000
$10.08-0.09-0.9%$10.17$10.25$10.061,783,000
$10.17-0.23-2.2%$10.35$10.37$10.082,479,500
$10.40-0.14-1.3%$10.74$10.74$10.253,599,500
$10.54+0.27+2.6%$10.46$10.65$10.274,442,500
$10.27+0.08+0.8%$10.25$10.54$10.253,349,000
$10.19+0.215+2.2%$10.03$10.30$9.8055,013,500
$9.975-0.335-3.2%$10.38$10.43$9.953,268,500
$10.31-0.07-0.7%$10.44$10.44$10.124,543,800
$10.38+0.33+3.3%$10.51$10.88$10.3319,557,000
Ticker
HKEX:2617
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
HKEX
Currency
HKD

What changed lately

Latest news

All TransThera Sciences (Nanjing). Inc. news

TransThera Sciences (Nanjing). Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
18 in the last 12 months · 18 in all · newest Nov 19, 2026 · oldest 2025

Where TransThera Sciences (Nanjing). Inc. is listed

ListingExchangeCountryCurrency
HKEX:2617 藥捷安康 · Home listing · This pageHKEXHong KongHKD
Frankfurt:J8JFrankfurtGermanyEUR

Valuation

Price/book 2.0× against a median of 2.0×: 5th lowest of 10 Biotechnology companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$935.9M HKD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
Negative EBITDA
Price/book
2.0×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
TransThera Sciences (Nanjing). Inc. · HKEX:2617US$257.1MUS$119.4Mn/an/an/a2.0×n/a0.0×n/a
Kyverna Therapeutics, Inc. · NASDAQ:KYTXUS$263.5MUS$117.8Mn/an/an/a2.0×n/a0.2×2.02
PepGen Inc. · NASDAQ:PEPGUS$261.8MUS$172.6Mn/an/an/a2.5×n/a0.1×1.11
Ocugen, Inc. · NASDAQ:OCGNUS$260.6MUS$178.1Mn/a37.3×n/an/an/an/a1.47
Altimmune, Inc. · NASDAQ:ALTUS$258.8MUS$28.73Mn/an/an/a0.6×n/a0.1×1.55
Prelude Therapeutics Incorporated · NASDAQ:PRLDUS$258.6MUS$136.2Mn/a6.3×n/a2.1×−247.1%0.1×1.48
OBI Pharma, Inc. · TPEX:4174US$258.5MUS$243.4Mn/a154×n/a5.7×n/a0.0×n/a
Eikon Therapeutics, Inc. · NASDAQ:EIKNUS$256.8MUS$44.67Mn/an/an/a0.7×n/a0.7×1.91
SAB Biotherapeutics, Inc. · NASDAQ:SABSUS$255.7MUS$156.5Mn/an/an/a1.2×n/a0.0×1.19
Evommune, Inc. · NYSE:EVMNUS$255.5MUS$86.86Mn/an/an/a1.0×n/a0.0×0.96
Editas Medicine, Inc. · NASDAQ:EDITUS$253.1MUS$119.7Mn/a2.4×n/a3.0×−144.9%0.7×2.22
Median of the othersUS$258.5MUS$128.0M21.8×2.0×−196.0%0.1×1.48

Forecasts

Analysts' consensus from EODHD, read Nov 11, 2026. Not 6ix's view and not investment advice.

Price target
19.06 HKD · Analysts' mean
EPS, year to Dec 2026
-0.74 · 1 analyst

Events

QuarterResultsShare move
Q2 2025Sep 19, 2025−19.4%
Q1 2025Jun 9, 2025

Open Events

Financials

Annual, in CNY

Income statement

LineFY2025FY2024FY2023FY2022FY2020FY2019
Revenue001.18M124.0K61.8M
Cost of revenue0003.40M
Gross profit001.18M124.0K-3.40M
Research and development246.8M244.0M379.0K297.3K76.5M72.2M
Selling, general and administrative54.8M47.7M43.0K56.3K
Operating income-300.2M-286.7M-390.5M-312.3M-43.9M-98.4M
Depreciation and amortization5.03M6.44M7.40M8.91M4.59M3.40M
EBITDA-295.2M-280.2M-383.1M-303.4M-39.3M-95.0M
Interest expense121.0K201.0K248.5K184.9K37.8M16.4M
Income before tax-296.0M-274.6M-350.6M-251.9M-74.5M-110.9M
Income tax6.23M
Net income-296.0M-274.6M-344.1M-250.0M-80.7M-110.9M
Earnings per share, basic-0.76-0.69-902.26-693.80-0.20-0.28

Balance sheet

LineFY2025FY2024FY2023FY2022FY2020FY2019
Cash and equivalents415.4M569.5M496.6M1.11B78.2M27.8M
Short-term investments73.7M3.03M341.5M473.4K201.1M
Receivables2.31M35.3M2.69M
Inventory212.0K173.0K160.0K277.5K
Current assets500.9M585.3M845.6M1.32B324.6M35.0M
Property, plant and equipment28.8M31.6M
Total assets545.9M629.6M887.1M1.35B344.9M50.1M
Accounts payable104.1M81.2M78.6M81.8M2.17M7.26M
Current liabilities129.5M103.4M102.6M109.9M105.2M12.9M
Total debt1.65M4.37M4.81M3.04M490.7M160.0M
Total liabilities129.5M104.6M103.9M111.0M578.9M200.4M
Shareholders' equity416.4M525.0M783.2M1.24B-233.9M-154.2M
Shares outstanding389.7M396.9M381.4K360.4K396.9M396.9M

Cash flow

LineFY2025FY2024FY2023FY2022FY2020FY2019
Cash from operations-253.5M-271.2M-319.3M-241.9M-66.7M-60.8M
Capital spending-164.0K-773.0K-11.8M-2.06M-9.93M-328.6K
Free cash flow-253.7M-272.0M-331.1M-244.0M-76.6M-61.2M
Cash from investing-68.0M348.4M-186.9M27.0M-195.8M35.7M
Cash from financing169.0M-4.87M15.8M240.5M311.5M19.5M
Share buybacks020.0M
Change in cash-154.1M72.9M-487.3M888.6M51.7M27.8M

Open Financials

Filings

FilingDateTypeFiled with
Next Day Disclosure ReturnNov 19, 2026Next day disclosure returnHKEX
INSIDE INFORMATION ANNOUNCEMENT COMPLETION OF THE H SHARE FULL CIRCULATIONNov 19, 2026Other filingsHKEX
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026Nov 3, 2026Monthly returnHKEX
Next Day Disclosure ReturnNov 2, 2026Next day disclosure returnHKEX
INSIDE INFORMATION ANNOUNCEMENT GRANT OF LISTING APPROVAL BY THE STOCK EXCHANGE FOR IMPLEMENTATION OF THE H SHARE FULL CIRCULATIONNov 1, 2026Other filingsHKEX
Next Day Disclosure ReturnOct 27, 2026Next day disclosure returnHKEX
INSIDE INFORMATION ANNOUNCEMENT ISSUANCE OF THE FILING NOTICE BY THE CSRC FOR THE H SHARE FULL CIRCULATION BY THE COMPANYOct 26, 2026Other filingsHKEX
Next Day Disclosure ReturnOct 26, 2026Next day disclosure returnHKEX
Next Day Disclosure ReturnOct 23, 2026Next day disclosure returnHKEX
Next Day Disclosure ReturnOct 22, 2026Next day disclosure returnHKEX
All 15 filings
FilingDateTypeFiled with
VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE ON COMMERCIALISATION OF CORE PRODUCT YOCHANRAOct 22, 2026Operations updateHKEX
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026Oct 5, 2026Monthly returnHKEX
INTERIM REPORT 2026Sep 21, 2026Interim reportHKEX
VOLUNTARY ANNOUNCEMENT FIRST PATIENT DOSED IN PHASE II CLINICAL TRIAL OF TINENGOTINIB IN COMBINATION WITH NOVEL HORMONAL THERAPY FOR PRETREATED AND PROGRESSED METASTATIC CASTRATION-RESISTANT PROSTATE CANCER IN CHINASep 18, 2026Operations updateHKEX
VOLUNTARY ANNOUNCEMENT INCLUSION OF YOCHANRA (TINENGOTINIB) IN THE CSCO GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF BILIARY TRACT CANCERS (2026)Sep 18, 2026Other filingsHKEX

Open Filings

Cap table

Built by 6ix from TransThera Sciences (Nanjing). Inc.’s releases

Common shares
312,486,673
Fully diluted
312,486,673

Fully diluted

LineShares
Common shares312,486,673

Share count over time

CountShares
Nov 22, 2026312,486,673

Open Cap table

Shareholders

Funds

HolderSharesValueAs of
BNY Mellon Emerging Markets Equity ETF500US$634Jul 31, 2026

Open Shareholders

Log in to ask 6ix AI your own questions about TransThera Sciences (Nanjing). Inc.